FDA Requires Updating Ozempic and Wegovy Labels Due to Potential Vision Risks
The FDA is requiring label updates for Ozempic, Wegovy, and other GLP-1 medications due to a possible link with the rare eye condition NAION, which can cause vision loss.
Read more →